Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
59
ZBIO Quote, Financials, Valuation and Earnings
Last price:
$43.29
Seasonality move
:
-1.59%
Day range:
$42.51 - $44.60
52-week range:
$5.83 - $44.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
120.60x
P/B ratio:
9.19x
Volume:
130.9K
Avg. volume:
357.5K
1-year change:
342.77%
Market cap:
$1.8B
Revenue:
$5M
EPS (TTM):
-$4.53
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $50M | $5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -90% | |
| Cost of Revenues | -- | -- | $78K | $113K | $137K | |
| Gross Profit | -- | -- | -$78K | $49.9M | $4.9M | |
| Gross Profit Margin | -- | -- | -- | 99.77% | 97.26% | |
| R&D Expenses | -- | -- | $61.6M | $60M | $139.1M | |
| Selling, General & Admin | -- | -- | $13.5M | $17.1M | $29.7M | |
| Other Inc / (Exp) | -- | -- | -$44.1M | -$9.7M | $7.3M | |
| Operating Expenses | -- | -- | $75.1M | $77M | $168.8M | |
| Operating Income | -- | -- | -$75.2M | -$27.1M | -$163.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$119.3M | -$36.8M | -$156.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $301K | $429K | |
| Net Income to Company | -- | -- | -$119.3M | -$37.1M | -$157M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$119.3M | -$37.1M | -$157M | |
| Basic EPS (Cont. Ops) | -- | -- | -$3.11 | -$0.97 | -$3.76 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$3.11 | -$0.97 | -$3.76 | |
| Weighted Average Basic Share | -- | -- | $38.3M | $38.3M | $41.8M | |
| Weighted Average Diluted Share | -- | -- | $38.3M | $38.3M | $41.8M | |
| EBITDA | -- | -- | -$75.1M | -$27M | -$163.8M | |
| EBIT | -- | -- | -$75.2M | -$27.1M | -$163.9M | |
| Revenue (Reported) | -- | -- | -- | $50M | $5M | |
| Operating Income (Reported) | -- | -- | -$75.2M | -$27.1M | -$163.9M | |
| Operating Income (Adjusted) | -- | -- | -$75.2M | -$27.1M | -$163.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $50M | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -100% | -- | |
| Cost of Revenues | -- | -- | $26K | $36K | $11K | |
| Gross Profit | -- | -- | $50M | -$36K | -$11K | |
| Gross Profit Margin | -- | -- | 99.95% | -- | -- | |
| R&D Expenses | -- | -- | $9.4M | $33.5M | $34.4M | |
| Selling, General & Admin | -- | -- | $5M | $7.5M | $13.2M | |
| Other Inc / (Exp) | -- | -- | -$16K | $2.4M | -- | |
| Operating Expenses | -- | -- | $14.4M | $40.9M | $47.6M | |
| Operating Income | -- | -- | $35.6M | -$41M | -$47.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | $35.6M | -$38.6M | -$51.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | $35.6M | -$38.6M | -$51.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $35.6M | -$38.6M | -$51.5M | |
| Basic EPS (Cont. Ops) | -- | -- | $0.85 | -$0.92 | -$1.22 | |
| Diluted EPS (Cont. Ops) | -- | -- | $0.85 | -$0.92 | -$1.22 | |
| Weighted Average Basic Share | -- | -- | $41.8M | $41.8M | $42.2M | |
| Weighted Average Diluted Share | -- | -- | $41.8M | $41.8M | $42.2M | |
| EBITDA | -- | -- | $35.7M | -$40.9M | -$47.6M | |
| EBIT | -- | -- | $35.6M | -$41M | -$47.6M | |
| Revenue (Reported) | -- | -- | $50M | -- | -- | |
| Operating Income (Reported) | -- | -- | $35.6M | -$41M | -$47.6M | |
| Operating Income (Adjusted) | -- | -- | $35.6M | -$41M | -$47.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $15M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $134K | $79K | |
| Gross Profit | -- | -- | $49.9M | -$134K | $14.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $55.4M | $110.4M | $161.5M | |
| Selling, General & Admin | -- | -- | $12.8M | $18.3M | $49.2M | |
| Other Inc / (Exp) | -- | -- | -$10.2M | $4.4M | -- | |
| Operating Expenses | -- | -- | $71.4M | $132.9M | $210.6M | |
| Operating Income | -- | -- | -$21.4M | -$133M | -$195.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$12.5M | -$128.7M | -$189.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $301K | $244K | |
| Net Income to Company | -- | -- | -- | -$129M | -$189.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$31.5M | -$129M | -$189.9M | |
| Basic EPS (Cont. Ops) | -- | -- | -$3.64 | -$3.28 | -$4.53 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.40 | -$3.28 | -$4.53 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -$21.2M | -$132.9M | -$195.6M | |
| EBIT | -- | -- | -$21.4M | -$133M | -$195.7M | |
| Revenue (Reported) | -- | -- | -- | -- | $15M | |
| Operating Income (Reported) | -- | -- | -$21.4M | -$133M | -$195.7M | |
| Operating Income (Adjusted) | -- | -- | -$21.4M | -$133M | -$195.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $50M | -- | $10M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $83K | $104K | $46K | |
| Gross Profit | -- | -- | $49.9M | -$104K | $10M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $39.6M | $90M | $112.3M | |
| Selling, General & Admin | -- | -- | $12.8M | $18.3M | $37.7M | |
| Other Inc / (Exp) | -- | -- | -$10.2M | $3.9M | $3.6M | |
| Operating Expenses | -- | -- | $52.3M | $108.2M | $150M | |
| Operating Income | -- | -- | -$2.4M | -$108.3M | -$140.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$12.5M | -$104.4M | -$137.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -$185K | |
| Net Income to Company | -- | -- | -$12.5M | -$104.4M | -$137.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$12.5M | -$104.4M | -$137.3M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.40 | -$2.64 | -$3.27 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.40 | -$2.64 | -$3.27 | |
| Weighted Average Basic Share | -- | -- | $118.4M | $118.4M | $125.8M | |
| Weighted Average Diluted Share | -- | -- | $118.4M | $118.4M | $125.8M | |
| EBITDA | -- | -- | -$2.3M | -$108.2M | -$140M | |
| EBIT | -- | -- | -$2.4M | -$108.3M | -$140.1M | |
| Revenue (Reported) | -- | -- | $50M | -- | $10M | |
| Operating Income (Reported) | -- | -- | -$2.4M | -$108.3M | -$140.1M | |
| Operating Income (Adjusted) | -- | -- | -$2.4M | -$108.3M | -$140.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $67.2M | $56.9M | $350.9M | |
| Short Term Investments | -- | -- | -- | -- | $31M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | $1.2M | $2.9M | $5.1M | |
| Total Current Assets | -- | -- | $68.4M | $59.8M | $355.9M | |
| Property Plant And Equipment | -- | -- | $1.8M | $1M | $1.2M | |
| Long-Term Investments | -- | -- | $86K | $86K | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | $212K | $186K | $217K | |
| Total Assets | -- | -- | $74.6M | $68.2M | $370M | |
| Accounts Payable | -- | -- | $5.8M | $5.4M | $17.1M | |
| Accrued Expenses | -- | -- | $15.1M | $11.9M | $30.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $715K | $556K | $785K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $26M | $23.3M | $57.3M | |
| Long-Term Debt | -- | -- | $812K | $20.6M | $218K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $26.8M | $43.8M | $57.5M | |
| Common Stock | -- | -- | $1K | $1K | $4K | |
| Other Common Equity Adj | -- | -- | -$41K | $37K | $194K | |
| Common Equity | -- | -- | -$192.3M | -$225.7M | $312.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $47.8M | $24.4M | $312.5M | |
| Total Liabilities and Equity | -- | -- | $74.6M | $68.2M | $370M | |
| Cash and Short Terms | -- | -- | $67.2M | $56.9M | $350.9M | |
| Total Debt | -- | -- | $812K | $20.6M | $218K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $72.3M | $386.8M | $290.9M | |
| Short Term Investments | -- | -- | -- | $26.8M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | $4.4M | $7M | -- | |
| Total Current Assets | -- | -- | $76.7M | $393.8M | $296.6M | |
| Property Plant And Equipment | -- | -- | $1.1M | $545K | $857K | |
| Long-Term Investments | -- | -- | -- | $89K | $10.7M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | $6M | $189K | -- | |
| Total Assets | -- | -- | $83.8M | $403.4M | $322M | |
| Accounts Payable | -- | -- | $2.3M | $15.1M | $6.4M | |
| Accrued Expenses | -- | -- | $8.6M | $22.3M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $583K | $384K | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $15.6M | $44M | $52.4M | |
| Long-Term Debt | -- | -- | $20M | -- | $180K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $286M | $44M | $125.6M | |
| Common Stock | -- | -- | $1K | $4K | $4K | |
| Other Common Equity Adj | -- | -- | $124K | $54K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -$202.2M | $359.4M | $196.4M | |
| Total Liabilities and Equity | -- | -- | $83.8M | $403.4M | $322M | |
| Cash and Short Terms | -- | -- | $72.3M | $386.8M | $290.9M | |
| Total Debt | -- | -- | -- | -- | $180K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$119.3M | -$37.1M | -$157M | |
| Depreciation & Amoritzation | -- | -- | $78K | $113K | $137K | |
| Stock-Based Compensation | -- | -- | $737K | $3.5M | $10.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$65.7M | -$30.5M | -$119.7M | |
| Capital Expenditures | -- | -- | $2.2M | $17K | $131K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$2.2M | -$17K | -$30.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $20M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$6.3M | |
| Cash From Financing | -- | -- | $59.4M | $20.1M | $413M | |
| Beginning Cash (CF) | -- | -- | $67.2M | $56.9M | $319.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$8.5M | -$10.4M | $262.9M | |
| Ending Cash (CF) | -- | -- | $58.7M | $46.6M | $582.9M | |
| Levered Free Cash Flow | -- | -- | -$67.9M | -$30.5M | -$119.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $35.6M | -$38.6M | -$51.5M | |
| Depreciation & Amoritzation | -- | -- | $26K | $36K | $11K | |
| Stock-Based Compensation | -- | -- | $1M | $2.8M | $7.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $31.8M | -$31.1M | -$41.1M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$26.8M | $40M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $20M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$439K | -- | |
| Cash From Financing | -- | -- | $20M | $234M | $72.6M | |
| Beginning Cash (CF) | -- | -- | $20.5M | $360M | $115.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | $4K | -$52K | $25K | |
| Additions / Reductions | -- | -- | $51.9M | $176.1M | $71.6M | |
| Ending Cash (CF) | -- | -- | $72.4M | $536.1M | $187.1M | |
| Levered Free Cash Flow | -- | -- | $31.8M | -$31.1M | -$41.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$129M | -$189.9M | |
| Depreciation & Amoritzation | -- | -- | -- | $134K | $79K | |
| Stock-Based Compensation | -- | -- | $2.4M | $6.5M | $24.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -$96.5M | -$158.5M | |
| Capital Expenditures | -- | -- | -- | $74K | $92K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$26.8M | -$162.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | $411.2M | $76.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $287.7M | -$244.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -$96.6M | -$158.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$12.5M | -$104.4M | -$137.3M | |
| Depreciation & Amoritzation | -- | -- | $83K | $104K | $46K | |
| Stock-Based Compensation | -- | -- | $2.4M | $5.3M | $18.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$15.1M | -$81.1M | -$119.9M | |
| Capital Expenditures | -- | -- | -- | $57K | $18K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$26.8M | -$158.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $20M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$1.9M | -- | |
| Cash From Financing | -- | -- | $20.1M | $411.1M | $74.4M | |
| Beginning Cash (CF) | -- | -- | $129.1M | $581.1M | $356.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | $165K | $16K | -$263K | |
| Additions / Reductions | -- | -- | $5.1M | $303.2M | -$204.3M | |
| Ending Cash (CF) | -- | -- | $134.2M | $884.3M | $151.6M | |
| Levered Free Cash Flow | -- | -- | -$15.1M | -$81.2M | -$119.9M | |
Get ZBIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ZBIO
Sector
P/E ratio
--
23.89x
PEG ratio
-0.25x
-0.01x
P/B ratio
9.19x
1.82x
Price / LTM sales
120.60x
1.60x
Growth Metrics
ZBIO
Sector
Revenue growth
--
4.62%
Earnings growth
-32.2%
10.88%
Revenue (5-year growth)
--
6.5%
Earnings forecast
-$0.85
-$0.21
Profitability
ZBIO
Sector
Profitability FY 2024
$4.9M
$3.5M
Return on invested capital
-67.98%
-31.77%
Return on assets
-55.13%
-27.96%
Return on equity
-68.2%
-37.63%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
17
Estimated Next Earnings Date
Feb
11
Balance Sheet
ZBIO
Sector
Total cash
$290.9M
$26.3M
Short term investments
$31M
$25.7M
Total assets
$370M
$78M
Long term debt
$180K
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
